PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY (STRATEGE) SHOWS THE EFFICACY OF TREAT-TO-TARGET STRATEGY AND METHOTREXATE MONOTHERAPY OPTIMIZATION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS

被引:0
|
作者
Flipo, R. -M. [1 ]
Gaujoux-Viala, C. [2 ,3 ]
Hudry, C. [4 ,5 ]
Zinovieva, E. [6 ]
Herman-Demars, H. [6 ]
机构
[1] Lille Univ Hosp Roger Salengro, Dept Rheumatol, Lille, France
[2] Nimes Hosp, Dept Rheumatol, Nimes, France
[3] Montpellier Univ, Montpellier, France
[4] Cochin Hosp, Rheumatol Inst, Paris, France
[5] Cochin Hosp, Rheumatol Dept, Paris, France
[6] Nord Pharma, Med Dept, Paris, France
关键词
D O I
10.1136/annrheumdis-2017-eular.2707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0057
引用
收藏
页码:789 / 789
页数:1
相关论文
共 50 条
  • [1] Prospective Observational Real-Life Study (STRATEGE) Shows the Efficacy of Treat-to-Target Strategy and Methotrexate Monotherapy Optimization in Patients with Established Rheumatoid Arthritis
    Flipo, Rene-Marc
    Gaujoux-Viala, Cecile
    Hudry, Christophe
    Zinovieva, Elena
    Leutenegger, Eric
    Herman-Demars, Helene
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] OUTCOMES OF TREAT-TO-TARGET STRATEGY IN ESTABLISHED RHEUMATOID ARTHRITIS: A LONG-TERM PROSPECTIVE COHORT STUDY
    Andrade, N. P. B. D.
    Chakr, R. M. D. S.
    Xavier, R. M.
    Viecceli, D.
    Correa, R.
    Oliveira Filho, C. M.
    Brenol, C. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 200 - 201
  • [3] Assessment of the treat-to-target strategy in patients with refractory rheumatoid arthritis A prospective study on efficacy and safety in a Saudi population
    Mohammed, R. H. A.
    Kewan, H. H.
    Bukhari, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (08): : 746 - 753
  • [4] Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study
    Bueno de Andrade, Nicole Pamplona
    da Silva Chakr, Rafael Mendonca
    Xavier, Ricardo Machado
    Viecceli, Daniela
    Bilycz Correa, Ricardo Henrique
    de Oliveira Filho, Cilomar Martins
    Brenol, Claiton Viegas
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 993 - 997
  • [5] Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study
    Nicole Pamplona Bueno de Andrade
    Rafael Mendonça da Silva Chakr
    Ricardo Machado Xavier
    Daniela Viecceli
    Ricardo Henrique Bilycz Correa
    Cilomar Martins de Oliveira Filho
    Claiton Viegas Brenol
    Rheumatology International, 2017, 37 : 993 - 997
  • [6] Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study
    Sugihara, Takahiko
    Ishizaki, Tatsuro
    Onoguchi, Wataru
    Baba, Hiroyuki
    Matsumoto, Takumi
    Iga, Shoko
    Kubo, Kanae
    Kamiya, Mari
    Hirano, Fumio
    Hosoya, Tadashi
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    RHEUMATOLOGY, 2021, 60 (09) : 4252 - 4261
  • [7] Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients
    Thomas, Konstantinos
    Lazarini, Argiro
    Kaltsonoudis, Evripidis
    Drosos, Alexandros
    Papalopoulos, Ioannis
    Sidiropoulos, Prodromos
    Tsatsani, Panagiota
    Gazi, Sousana
    Pantazi, Lina
    Boki, Kyriaki A.
    Katsimbri, Pelagia
    Boumpas, Dimitrios
    Fragkiadaki, Kalliopi
    Tektonidou, Maria
    Sfikakis, Petros P.
    Karagianni, Konstantina
    Sakkas, Lazaros I.
    Grika, Eleftheria P.
    Vlachoyiannopoulos, Panagiotis G.
    Evangelatos, Gerasimos
    Iliopoulos, Alexios
    Dimitroulas, Theodoros
    Garyfallos, Alexandros
    Melissaropoulos, Konstantinos
    Georgiou, Panagiotis
    Areti, Maria
    Georganas, Constantinos
    Vounotrypidis, Periklis
    Kitas, George D.
    Vassilopoulos, Dimitrios
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [8] PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY
    Moller-Bisgaard, S.
    Georgiadis, S.
    Horslev-Petersen, K.
    Ejbjerg, B.
    Hetland, M. L.
    Ornbjerg, L.
    Glinatsi, D.
    Moller, J. Mollenbach
    Boesen, M.
    Stengaard-Pedersen, K.
    Madsen, O. Rintek
    Jensen, B.
    Villadsen, J.
    Hauge, E. M.
    Bennett, P.
    Hendricks, O.
    Asmussen, K.
    Kowalski, M.
    Lindegaard, M.
    Bliddal, H.
    Krogh, N. Steen
    Ellingsen, T.
    Nielsen, A.
    Balding, L.
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1401 - 1401
  • [9] Treat-to-target strategy in patients with rheumatoid arthritis: Audit adherence from real world clinical data
    Andreu, Jose-Luis
    Auxiliadora Martin, Maria
    Corominas, Hector
    Javier Perez-Venegas, Jose
    Andres Roman-Ivorra, Jose
    Sanchez-Alonso, Fernando
    Gil de Miguel, Angel
    REUMATOLOGIA CLINICA, 2021, 17 (04): : 212 - 214
  • [10] EFFICACY OF TREAT-TO-TARGET BIOLOGIC THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED TO DELAYED INITIATION OF BIOLOGICS: A REAL WORLD STUDY
    Lampropoulos, C. E.
    Orfanos, P.
    Manoussakis, M.
    Tzioufas, A.
    Moutsopoulos, H. M.
    Vlachoyiannopoulos, P. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 193 - 193